NATALIE FLOYD: Open Payments
NPI 1699245860 · HAWKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 60 payments from 27 companies in 2025. Trend: 2023 $1,785 · 2024 $1,146 · 2025 $1,431
Food & beverage: $1,338Education: $93
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Regeneron Healthcare Solutions, Inc. | 4 | $97 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| PFIZER INC. | 5 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| Daiichi Sankyo Inc. | 3 | $83 |
| GENZYME CORPORATION | 3 | $79 |
| BeOne Medicines USA, Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
| Vanda Pharmaceuticals Inc. | 4 | $68 |
Products named: SARCLISA, ENHERTU, BRUKINSA, LIBTAYO, KISQALI, IBRANCE, FANAPT, RYTELO.
Industry payments across GA — which companies pay providers there.
